Lymph node classification in E‑PSMA reporting guidelines for PSMA‑PET

TY - JOUR

T1 - Lymph node classification in E‑PSMA reporting guidelines for PSMA‑PET

AU - Oprea-Lager, Daniela E.

AU - Ceci, Francesco

AU - Eiber, Matthias

AU - Fanti, Stefano

AU - Herrmann, Ken

N1 - Funding Information: Daniela E. Oprea-Lager reports unrestricted grants from Janssen for Consensus meetings attendance, outside the submitted work. Francesco Ceci declares no competing interests in relation with the submitted work. Matthias Eiber reports prior consulting activities for BED, Novartis, Telix, Progenics, Bayer, Point Biopharma, and Janssen and a patent application for rhPSMA, all outside the submitted work. Stefano Fanti reports personal fees from ANMI, Astellas, Bayer, Blue Earth Diagnostics, GE Healthcare, Janssen, Novartis, and Sofie Biosciences, and nonfinancial support from Advanced Accelerator Applications (AAA), Bayer, GE Health- care, Curium, Tema Sinergie, Sanofi, and Telix, outside the submitted work. Ken Herrmann reports personal fees from Bayer, SIR- TEX, Adacap, Curium, Endocyte, BTG, Ipsen, Siemens Healthineers, GE Healthcare, Amgen, Novartis, and Y-mAbs; stock options in Sofie Bio-sciences; nonfinancial support from ABX; and grants from BTG, outside the submitted work.

PY - 2022/12

Y1 - 2022/12

UR - https://www.scopus.com/pages/publications/85140088957

U2 - 10.1007/s00259-022-06007-0

DO - 10.1007/s00259-022-06007-0

M3 - Letter

C2 - 36241913

AN - SCOPUS:85140088957

SN - 1619-7070

VL - 50

SP - 10

EP - 11

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

IS - 1

ER -